Research Article
A Genomic-Clinicopathologic Nomogram for the Prediction of Lymph Node Invasion in Prostate Cancer
Table 2
Univariate and multivariate logistic analyses in the SMOTE-balanced training set.
| Variable | Univariate analysis | Multivariate analysis | β | OR (95% CI) | value | β | OR (95% CI) | value |
| Age (continuous), years | 0.004 | 1.004 (0.961–1.049) | 0.868 | — | — | — | PSA level (most recent) | 0.021 | 1.021 (0.959–1.086) | 0.516 | — | — | — | Clinical stage | 0.501 | 1.650 (1.041–2.615) | 0.033 | — | — | — | Gleason grade | 1.098 | 2.997 (2.102–4.272) | <0.001 | 1.071 | 2.919 (1.962–4.343) | <0.001 | Risk score | 2.590 | 13.334 (6.888–25.815) | <0.001 | 2.539 | 12.670 (6.211–25.847) | <0.001 |
|
|
CI: confidence interval; OR, odds ratio; PSA: prostate-specific antigen; SMOTE: synthetic minority oversampling technique.
|